Takatsuki, Japan

Shinji Narisawa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Narisawa. Retrieved from https://idiyas.com/inventor/shinji-narisawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shinji Narisawa: Innovator in Controlled Release Pharmaceutical Preparations

Introduction

Shinji Narisawa is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His innovative work has led to the creation of a unique pharmaceutical preparation that enhances the efficacy of active substances.

Latest Patents

Narisawa holds a patent for "Controlled release succinic acid microcapsules coated with aqueous." This invention comprises a core containing a pharmaceutically active substance and an organic acid, along with a coating film formed from a water-insoluble and water-slightly permeable acrylic polymer. This formulation allows for well-controlled dissolution and release of the active substance, maintaining the desired blood level for an extended period. The patent highlights a method for producing this preparation, showcasing Narisawa's expertise in pharmaceutical technology. He has 1 patent to his name.

Career Highlights

Shinji Narisawa is associated with Tanabe Seiyaku Company, Limited, where he has contributed to various research and development projects. His work focuses on improving drug delivery systems and enhancing the therapeutic effects of medications. Narisawa's dedication to innovation has positioned him as a key figure in his field.

Collaborations

Throughout his career, Narisawa has collaborated with esteemed colleagues, including Kazuo Noda and Yoshiyuki Hirakawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Shinji Narisawa's contributions to controlled release pharmaceutical preparations demonstrate his commitment to innovation in the field. His patent reflects a significant advancement in drug delivery technology, which has the potential to improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…